SCRI

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

SCRI
Nov 28, 2024, 12:35 | Blog
David R. Spigel: Putting the Pieces Together - Looking at Lung Cancer
David R. Spigel, Chief Scientific Officer at Sarah Cannon Research Institute, shared a post on…
Nov 26, 2024, 23:03 | Blog
Ishwaria Subbiah: Let's Honor the Dedication of Unsung Heroes During National Family Caregivers Month
Ishwaria Subbiah, Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research…
Nov 21, 2024, 16:00 | Blog
Mark E. Cooper will be joining SCRI to help coordinate a comprehensive breast program
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Nov 20, 2024, 19:12 | Blog
Reflecting on Progress and Partnerships in Lung Cancer Care – Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Dr. Robert Jotte, Disease Chair, Lung Cancer…
Nov 15, 2024, 16:13 | Blog
Vivek Subbiah: An enlightening panel discussion on the latest advancements in oncology at SCRI meeting
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Nov 11, 2024, 02:47 | Insight
Erika Hamilton - Candidate for ASCO Nominating Committee
Erika Hamilton has been nominated as the Undesignated Member Candidate of the nomination committee for…
Nov 4, 2024, 13:28 | Insight
Strategies to prevent and manage antibody-drug conjugate-associated nausea and vomiting
Sarah Cannon Docs shared a post on X: “SCRI breast cancer expert Erika Hamilton, joins…
Oct 26, 2024, 17:15 | Blog
Vivek Subbiah: Welcoming Deepak Bhamidipati to Sarah Cannon Research Institute Early Phase Drug Development Unit
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
Oct 25, 2024, 08:46 | Blog
Vivek Subbiah: SCRI Phase 1 Denver DDU is celebrating its 10th anniversary
Razelle Kurzrock shared a post by Vivek Subbiah on X: "I know some of those…
Oct 22, 2024, 23:24 | Blog
Deepak Bhamidipati appointed as Assistant Director of Drug Development at SCRI
SCRI (Sarah Cannon Research Institute) shared a post on LinkedIn: ''We are thrilled to welcome…
Oct 18, 2024, 15:35 | Blog
Sarah Cannon Research Institute Partners with BostonGene to integrate molecular testing and informatics platforms
Sarah Cannon Research Institute shared a post by BostonGene on LinkedIn, adding: "We are excited to…
Oct 12, 2024, 12:57 | Blog
Jenna Fischer's recent breast cancer battle inspires a conversation around early detection and stage 1 triple positive breast cancer treatment - SCRI
SCRI (Sarah Cannon Research Institute) shared a post on LinkedIn: "Important Update: We hope you had…
Oct 10, 2024, 15:23 | Blog
Erika Hamilton: The Importance of Mammograms - Early Detection Saves Lives
Erika Hamilton shared a post on LinkedIn: "Many of us can recall a time in our…
Sep 28, 2024, 15:01 | Blog
OncoInfluencers to Follow on Social Media: Dr. Ishwaria Subbiah
We are excited to feature Dr. Ishwaria Subbiah as a prominent voice in the oncology…
Sep 1, 2024, 16:26 | Blog
Vivek Subbiah: Clinical trial vs fiction
Vivek Subbiah shared an article on LinkedIn: ''Every single drug, medicine, and treatment you’ve ever…
Aug 3, 2024, 11:42 | Blog
Ishwaria Subbiah: Privileged to present at the July 1 Rounds of the FDA Oncology Center of Excellence
Ishwaria Subbiah shared a post on LinkedIn: "That's a wrap! July 2024 took me to…
Aug 3, 2024, 02:30 | Blog
Advancing clinical trials at the SCRI Clinical Trials Symposium
Singapore Clinical Research Institute (SCRI) shared on LinkedIn: "We are heartened by the enthusiasm and…
Aug 1, 2024, 15:05 | Blog
Learn about opportunities to join - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Our team members are deeply committed to…
Jul 14, 2024, 08:27 | Stories
Douglas Flora: My career changed by a few thoughtful ‘grownup’ oncologists
Douglas Flora posted LinkedIn: “Great callout, Robin Zon! Looking back, I had two similar chance…
Jul 1, 2024, 15:15 | Blog
Cesar Perez: Increasing the Impact of Immunotherapy
Cesar Perez, Director of Drug Development at Lake Nona DDU of Florida Cancer Specialists and…
Jun 4, 2024, 03:22 | Blog
Vivek Subbiah: Our amazing CSO Dr. Spigel will be presenting at the big plenary!
Vivek Subbiah shared on X/Twitter: "ASCO24 Sunday morning! Starting the day with Skip Burris, Conquer Cancer,…
May 22, 2024, 08:29 | Blog
Vivek Subbiah: Let's celebrate the power of research and the hope
Vivek Subbiah shared on LinkedIn: "On this Clinical Trials Day, I’m immensely grateful for the incredible…
May 16, 2024, 10:02 | Blog
Updated Breast Cancer Screening Recommendation - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn: "Updated Breast Cancer Screening Recommendation. SCRI breast cancer…
Apr 30, 2024, 11:32 | Opinion
Ishwaria Subbiah: Colleagues with a sense of humor are priceless!
Ishwaria Subbiah shared on LinkedIn: "Colleagues with a sense of humor are priceless! Oncology is…
Apr 15, 2024, 21:22 | Blog
Michelyn Smith: Let's spread awareness about clinical trials
Michelyn Smith, Head of Talent Acquisition at Sarah Cannon Research Institute, shared a post by Vivek…
Mar 12, 2024, 10:02 | Blog
Vivek Subbiah: Grateful to have Jason Dorsey deliver a phenomenal and energetic keynote at the 27th Annual Scientific Meeting of SCRI! 
Vivek Subbiah shared a post on LinkedIn: "Grateful to have Jason Dorsey an acclaimed speaker, deliver…
Mar 10, 2024, 21:03 | Blog
Vivek Subbiah: Research should be standard-of-care and standard-of-care should be research
Vivek Subbiah recently posted on LinkedIn: "Yes! “Research should be standard-of-care and standard-of-care should be research”!!!…
Feb 21, 2024, 18:18 | Insight
Vivek Subbiah: As of December 31, 2023, the FDA had become aware of 22 cases of T-cell cancers that occurred after treatment with CAR-T products
Vivek Subbiah shared on LinkedIn: "Perspective article on 'Secondary Cancers after Chimeric Antigen Receptor T-Cell…
Dec 22, 2023, 14:02 | Blog
Benjamin Garmezy: The first day of our new practice at SCRI Oncology Partners in Nashville
Benjamin Garmezy, Associate Director of Genitourinary Research at Sarah Cannon Research Institute, shared a post…
Nov 7, 2023, 02:43 | Positive
Ishwaria Subbiah: I’ll never forget meeting Michael Davis
Ishwaria Subbiah shared on Twitter: "On this 1-yr anniversary of our SCRI-US Oncology research partnership,…
Sep 9, 2023, 08:15 | Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 3
On August 26th, which marks Women's Equality Day in the United States, OncoDaily began featuring…
All: 31 Posts: 1 - 100
Special Coverage